Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026.
According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor investors at Rs 45 per share, at the upper end of the Rs 42- 45 per share price band. Bandhan Small Cap Fund emerged as the sole domestic mutual fund participant in the anchor round and was allotted 26.66 lakh shares worth Rs 12 crore. Other anchor investors include Ampersand Growth Opportunities Fund Scheme-I, CP Capital Ltd, Visionary Value Fund, and Innovative Vision Fund.
The Rs 139-crore IPO is structured entirely as an offer-for-sale (OFS) of over 3.08 crore equity shares by existing promoters, with no fresh issue component. At the upper price band of Rs 45, the total issue size is pegged at Rs 138.87 crore. The company has stated that the purpose of the proposed listing is to enhance its visibility, strengthen brand recognition, and provide liquidity to existing shareholders.
Founded in 1993, Hexagon Nutrition began as a micronutrient formulations business before diversifying into branded nutrition products. The company’s portfolio today spans health, wellness, and clinical nutrition segments under brands such as Pentasure, Obesigo, and Pediagold. Its product range includes micronutrient premixes, therapeutic nutrition, clinical nutrition, wellness products, and fortified foods, with a commercial presence across 75 countries.
Shares of Hexagon Nutrition are expected to be listed on the Indian stock exchanges on June 12, 2026, subject to successful subscription and allotment processes.
